Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Neurology

Search Medical Condition
Please enter condition
Please choose location

Memory Problems Clinical Trials

A listing of Memory Problems medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (45) clinical trials

Some forgetfulness can be a normal part of aging. However, some people have more memory problems than other people their age. This condition is called mild cognitive impairment, or MCI. People with MCI can take care of themselves and do their normal activities, but they may lose things often, forget ...

Phase

The purpose of this study is to evaluate Donepezil and Memantine for the treatment of Alzheimer's disease.

Phase

Do you or someone you know have worsening memory or mild cognitive impairment? Then you may be interested in the EXPEDITION-PRO clinical research study. We're looking for volunteers to help us find out whether an investigational medication can slow the rate of cognitive and functional decline. To learn more please ...

Phase N/A

The name of this trial is MissionAD1. This 24-month treatment, multicenter, double-blind, placebo-controlled, parallel group, Phase 3 study in participants with Early Alzheimer's Disease (EAD) including mild cognitive impairment (MCI) due to AD/Prodromal AD and the early stages of mild AD will be conducted to evaluate the efficacy and safety ...

Phase

Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials.

Phase N/A

A 24-month, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, Safety, Tolerability, Biomarker, and Pharmacokinetic Study of AZD3293 in Early Alzheimer’s Disease (The AMARANTH Study).

Phase N/A

We are recruiting for the following populations: Age 50 to 80 Experiencing a decline in memory Or already diagnosed with Alzheimer’s disease (mild to moderate stage) The study involves one screening visit. If you qualify for the research study, the procedures will be done on the same day. If you ...

Phase N/A

The primary objective is to evaluate the efficacy and safety of phosphatidylserine (PS) on cognitive abilities in MCI

Phase

DAYBREAK-ALZ — the study will last 8 weeks to see if you qualify, plus 3 years of treatment, then 4 weeks of follow-up. The study drug is a tablet, to be taken once a day. The tablet will contain either a lower dose of the study drug, a higher dose ...

Phase